| Illustration by The Project Twins |
When the smoke finally cleared from the epic Allergan-Valeant takeover battle, everybody walked away richer, from Pershing Square Capital Management’s Bill Ackman to Och-Ziff Capital Management Group’s Dan Och to Paulson & Co.’s
